Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventor Develops Dosage Indicating Insulin Syringe (LGI-2593)


PITTSBURGH, June 25, 2018 /PRNewswire/ -- When not properly managed, diabetes can cause serious and even life-threatening complications. Individuals with diabetes use insulin to manage their glucose levels, a medication administered via syringe.

InventHelp Logo (PRNewsfoto/InventHelp)

An inventor from Hauppauge, N.Y., has invented the patent-pending JB INSULIN SYRINGE, a modified syringe that aids patients when administering insulin. "I have been a nurse for 17 years and have recognized the need for a product that provides an accurate visualization of correct dosages of insulin," said the inventor. "My invention would help to promote safety within the diabetic population." JB INSULIN provides users with a visual indication of the amount of liquid in a syringe, helping patients and caregivers to accurately dose clear injectable medications, particularly insulin.

This invention provides an increased peace of mind and comfort for people who take insulin and other injectable medication. Additionally, it fosters independence and empowerment associated with self-management of a chronic disease like diabetes. It is easy to use and helps patients and caregivers to administer the correct dosage every time.

The original design was submitted to the Long Island office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 17-LGI-2593, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 13:33
EHN Canada proudly announces a significant regional expansion of EHN Bellwood's legacy in pioneering addiction and mental health treatment centres....

at 13:30
CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partners CARBIOS' first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major step forward in the...

at 13:25
CBL-514 is the first product to treat cellulite at the raised areas.Currently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034.CBL-0201EFP...

at 13:15
The Board of Governors of the Canadian Memorial Chiropractic College (CMCC) is delighted to announce the appointment of Dr. Christine Bradaric-Baus as its next President, effective July 1, 2024, following the retirement of President...

at 13:13
Hoag is proud to announce the recruitment of cancer researchers and subspecialized oncologists Monica Mita, M.D., M.Sc., Mh.D.S., and Alain Mita, M.D., M.Sc., to the Hoag Family Cancer Institute....

at 13:02
Sorcero, the leading provider of advanced AI solutions purpose-built for life sciences, today announced the release of Scientific Sentiment, enabling Life Sciences teams, for the first time, to quantify product perception across KOLs and the market...



News published on and distributed by: